FDA+ roundup: Biden's scientific leadership in major flux; Cures 2.0 and ARPA-H to be packaged together
President Joe Biden’s administration is in a scientific pickle.
The White House’s top scientist Eric Lander resigned earlier this week, after demeaning women in his office.
Rob Califf, the White House’s choice to lead the FDA, after a year of silence, is now battling an internal revolt from Democrats that doesn’t have much to do with his résumé.
NIH Director Francis Collins has resigned, with no clear path for a replacement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
